"Federal Health Officials Discuss Marijuana Rescheduling Amid DEA Absence"
TL;DR
Federal health officials discussed the implications of marijuana research and potential rescheduling of cannabis from Schedule I to Schedule III, highlighting the ongoing challenges and uncertainties for researchers. Despite the absence of a DEA official, the conference emphasized the need for clearer regulations to facilitate cannabis studies, with hopes that rescheduling will ease research barriers.
Topics:businesshealth-policy#cannabinoids#cannabis-rescheduling#dea#federal-health-agencies#health-policy#marijuana-research
- Federal Health Officials Discuss Marijuana Research And Rescheduling Implications, But DEA Cancels Scheduled Appearance Marijuana Moment
- Marijuana Reclassification Unlikely to Mean Any Changes for Troops and Veterans, at Least for Now Military.com
- Proposed Cannabis Reschedule Sidesteps State Law Effects The National Law Review
- Biden's Destructive Pot Gambit City Journal
- How Making Cannabis a Schedule III Drug Could Affect Oregon's Green Future Willamette Week
Want the full story? Read the original reporting
Read on Marijuana Moment